About: The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1999 (uk) im März 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1999 (ast) scientific article published on 01 March 1999 (en)
publication date	wds:Q74623998-07457796-1AA9-4512-9525-A5D0502F5F78
publication date	1999-03-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q74623998-71303692-C065-41D8-9097-E2C3863C7A30
exact match	https://scigraph.springernature.com/pub.10.1038/sj.leu.2401341
author name string	wds:Q74623998-09DEA074-1EA2-4880-96B9-688E38F0DF49 wds:Q74623998-14E1A4DF-B74C-454E-8669-5A968A18492C wds:Q74623998-2FE38599-4040-4D48-8067-2DB80EFFD1F9 wds:Q74623998-3D0C8CDB-F3F7-4D78-827A-7092FC4B4D65 wds:Q74623998-47305021-70D8-414E-B744-E4460176E9C9 wds:Q74623998-4DB4F389-91A9-46F0-A52C-09D8F3B8E168 wds:Q74623998-6704E07C-E96F-47FB-B488-BA08615EAA5A wds:Q74623998-79A80D59-B669-4BDB-91C1-22C70F8D5050 wds:Q74623998-87A4F0D9-16DD-4BC1-9C28-B8D313CDA9A3 wds:Q74623998-882451AC-6083-4918-8769-3BC5C98D76DE wds:Q74623998-8AACCDB7-B90E-438D-A33E-43A918617C45 wds:Q74623998-8F842E65-F1C7-4672-B944-0D6AE02D7EE3 wds:Q74623998-B0813B45-F0E9-403E-A48B-7E197F98B359 wds:Q74623998-C1861C9B-454C-4E68-8D71-6EEA7D7629CE wds:Q74623998-D6859086-FC84-4519-AB1D-ABE210311EFF wds:Q74623998-D8B70642-5F0B-49A0-A6BB-310BC814DEE0 wds:Q74623998-DE00F3DA-4911-4D4F-A236-DFC3B5C9306A wds:Q74623998-EBB185DB-312A-4CBA-8179-49C983859ED7 wds:Q74623998-F9830189-E839-4E2E-9DEB-71F8190B49CC
author name string	H Ogawa T Kishimoto K Inoue H Sugiyama Y Oka M Kawakami K Ohyashiki K Toyama E H Kim M Tomonaga K Aozasa J H Ohyashiki H Iwama T Soma H Tamaki Y Oji A Tsuboi K Fuchigami T Tatekawa
rdfs:label	The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes (en) The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes (nl)
skos:prefLabel	The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes (en) The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes (nl)
name	The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes (en) The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes (nl)
title	wds:Q74623998-3B98E0A1-6E9B-4F5C-9314-3380763FCCDA
title	The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes (en)
page(s)	wds:Q74623998-CD65AA44-72A6-42C1-B666-D461E1570222
page(s)	393-399
instance of	wds:Q74623998-EFEBE2A9-764C-48CB-AA1A-4B4E9898499F
instance of	scholarly article
PubMed ID	wds:Q74623998-DF3E7BEF-7999-488F-A1DB-B5AD47CA3CA4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10086730
PubMed ID	10086730
published in	wds:Q74623998-C8717F66-3D6D-429C-947C-3EB85171E576
published in	Leukemia
issue	wds:Q74623998-5834AE1B-17D5-48E8-BEEB-7A7F6C47F2BD
volume	wds:Q74623998-F5ABB288-2A23-4D5B-AE88-2701493D6463
issue	3
volume	13
DOI	wds:Q74623998-F35CB7A2-F8D8-4D53-8DC5-F8F93CBFBF65
DOI	http://dx.doi.org/10.1038/SJ.LEU.2401341
DOI	10.1038/SJ.LEU.2401341
Dimensions Publication ID	wds:Q74623998-B344E044-F5CB-4562-95F4-8B5324E634F7
Dimensions Publication ID	1003770443
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74623998
is cites work of	A tumor suppressor and oncogene: the WT1 story. Prognostic impact of WT1 expression prior to hematopoietic stem cell transplantation in children with malignant hematological diseases Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation Wilms' tumour gene 1 (WT1) in human neoplasia. Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies WT1 proteins: functions in growth and differentiation A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression Wilms tumor gene (WT1) expression as a panleukemic marker FGFR1 and WT1 are markers of human prostate cancer progression The coexpression of the apoptosis-related genes bcl-2 and wt1 in predicting survival in adult acute myeloid leukemia Tumor suppressor genes in normal and malignant hematopoiesis Wilms' tumor gene WT1: its oncogenic function and clinical application Minimal residual disease diagnostics in myeloid malignancies in the post transplant period NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation. WT1 marker is not sufficient for distinguishing between melanoma and melanocytic nevi Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia. Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software